Results 111 to 120 of about 328 (142)
A 7-methoxytacrine-4-pyridinealdoxime hybrid as a novel prophylactic agent with reactivation properties in organophosphate intoxication. [PDF]
Nepovimova E +12 more
europepmc +1 more source
Oximes: inhibitors of human recombinant acetylcholinesterase. A structure-activity relationship (SAR) study. [PDF]
Sepsova V +6 more
europepmc +1 more source
Neurosteroids for the potential protection of humans against organophosphate toxicity. [PDF]
Reddy DS.
europepmc +1 more source
Detoxification of Organophosphate Poisoning Using Nanoparticle Bioscavengers. [PDF]
Pang Z +11 more
europepmc +1 more source
Towards Completion of the "Periodic Table" of Di-2-Pyridyl Ketoxime. [PDF]
Stamou C +4 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Pediatric poisoning from trimedoxime (TMB4) and atropine automatic injectors
The Journal of Pediatrics, 2005To describe the effects of combined trimedoxime (TMB4) and atropine poisoning from automatic injectors (AI) in children.Data was collected from two sources: calls to the Israel Poison Information Center (IPIC) during a 1-year period and a cohort of children who presented to pediatric emergency departments (EDs) after unintentional injection of an AI ...
Eran, Kozer +5 more
openaire +2 more sources
Civilian Adult Self Injections of Atropine – Trimedoxime (TMB4) Auto-Injectors
Clinical Toxicology, 2006The clinical effects of self injections of atropine-trimedoxime auto-injectors distributed to the civilian population as a field antidote for nerve agent attack were assessed.Data on self injections by adults (> or = 18 years) were collected from the Israel Poison Information Center and a hospital Emergency Department's records during a 2-year period ...
Yedidia, Bentur +7 more
openaire +2 more sources
Trimedoxime and HI‐6: Kinetic Comparison after Intravenous Administration to Mice
Pharmacology & Toxicology, 1996Abstract: The intravenous pharmacokinetics of the oximes HI‐6 (pyridinium‐1‐(((4‐carbamoi 1‐pyridinio)metoxy)rnethyl)‐2‐(hydroxyiminomethyl)dichloride monohydrate), (132.54 μmol/kg) and trimedoxime (1,1′‐(1,3′‐propanedyl)bis((4‐hydroxyimino) methyl)‐pyridinium dibromide), (55,98 μmol/kg) in mice was investigated. The concentrations of oximes in plasma
B, Milic, M, Maksimovic, M, Nedelijkovic
openaire +2 more sources
Journal of Applied Toxicology, 2011
ABSTRACTK027 [1‐(4‐hydroxyiminomethylpyridinium)‐3‐(4‐carbamoylpyridinium)–propane dibromide] is a promising new reactivator of organophosphate‐ or organophosphonate‐inhibited acetylcholinesterase (AChE) with low acute toxicity and broad spectrum efficacy. The aim of the present study was to compare the pharmacokinetics of both compounds.
Jana Zdarova, Karasova +5 more
openaire +2 more sources
ABSTRACTK027 [1‐(4‐hydroxyiminomethylpyridinium)‐3‐(4‐carbamoylpyridinium)–propane dibromide] is a promising new reactivator of organophosphate‐ or organophosphonate‐inhibited acetylcholinesterase (AChE) with low acute toxicity and broad spectrum efficacy. The aim of the present study was to compare the pharmacokinetics of both compounds.
Jana Zdarova, Karasova +5 more
openaire +2 more sources

